← GODS Home
♧
Cumin
Ingredient · 7 compounds · 2 conditions
Cumin is profiled across the CytoSolve® knowledge base and mapped to the disease biology it influences — tracing each of its compounds through disease, biological process, molecular pathway and down to individual biomarkers, with source videos and references at each step.
Compounds in this ingredient
Conditions addressed
Comparison
Ingredient → Compounds → Diseases → Biological Processes → Molecular Pathways → Biomarkers
All
Compound
Disease
Biological Process
Molecular Pathway
Compound · 2 disease(s) · 2 pathway(s)▸
Compound · 2 disease(s) · 2 pathway(s)
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ LPS Signaling
◆COX-2
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Lipid Metabolism1 pathway
▸▣ TRPA1 Signaling
◆Fatty acid (FA)
Compound · 2 disease(s) · 4 pathway(s)▸
Compound · 2 disease(s) · 4 pathway(s)
Disease · 2 process(es) · 3 pathway(s)▸
Disease · 2 process(es) · 3 pathway(s)
▸✣ Inflammation2 pathways
▸▣ NF-κB Signaling
▸▣ MAPK Signaling
▸✣ Apoptosis1 pathway
▸▣ PI3K/AKT/mTOR Signaling
◆p-AKT, p-mTOR
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Lipid Metabolism1 pathway
▸▣ β3-AR/PPAR-γ Signaling
◆PPAR-γ, UCP1, Fatty acid
Compound · 2 disease(s) · 3 pathway(s)▸
Compound · 2 disease(s) · 3 pathway(s)
Disease · 1 process(es) · 2 pathway(s)▸
Disease · 1 process(es) · 2 pathway(s)
▸✣ Inflammation2 pathways
▸▣ NF-κB Signaling
◆TNF-α, IL-1β, IL-6
▸▣ MAPK Signaling
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Lipid Metabolism1 pathway
▸▣ AKT/mTOR Signaling
◆AST, ALT, and ALP
Compound · 1 disease(s) · 1 pathway(s)▸
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Inflammation1 pathway
▸▣ LPS Signaling
◆TNF-α, IL-6, iNOS
Compound · 2 disease(s) · 5 pathway(s)▸
Compound · 2 disease(s) · 5 pathway(s)
Disease · 3 process(es) · 4 pathway(s)▸
Disease · 3 process(es) · 4 pathway(s)
▸✣ Apoptosis1 pathway
▸▣ PI3K/AKT Signaling
◆BAX/BCL-2 ratio
▸✣ Cell Cycle Progression2 pathways
▸▣ PI3K/AKT Signaling
◆p21, cyclin B1, CDK-1
▸▣ FAK/AKT Signaling
◆p21, cyclin B1, CDK-2
▸✣ Epithelial-Mesenchymal Transition1 pathway
▸▣ PI3K/AKT/mTOR Signaling
◆N-cadherin, vimentin, E-cadherin, Fibronectin
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Lipid Metabolism1 pathway
▸▣ AMPK/SREBP Signaling
◆AMPK
Compound · 2 disease(s) · 3 pathway(s)▸
Compound · 2 disease(s) · 3 pathway(s)
Disease · 2 process(es) · 2 pathway(s)▸
Disease · 2 process(es) · 2 pathway(s)
▸✣ Inflammation1 pathway
▸▣ MAPK Signaling
▸✣ Oxidative Stress1 pathway
▸▣ Oxidative Stress Signaling
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Lipid Metabolism1 pathway
▸▣ PPAR-γ Signaling
◆Fatty acid (FA)
Compound · 1 disease(s) · 1 pathway(s)▸
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)▸
Disease · 1 process(es) · 1 pathway(s)
▸✣ Oxidative Stress1 pathway
▸▣ Nrf2 Signaling
◆HO-1, ROS